A Phase 1 Study of the APE1 Protein Inhibitor APX3330 in Patients with Advanced Solid Tumors
APX3330
Presented at the American Society of Clinical Oncology (Chicago)
Filter by:
Ocuphire Pharma – Innovation Showcase
Conference Video Presentations
Presented at the American Society of Cataract and Refractive Surgery – Ophthalmology Innovation Summit (San Diego)
APX3330 Promotes Neurorestorative Effects after Stroke in Type One Diabetic Rats
APX3330
Aging and Disease 2018
Phentolamine Mesylate Ophthalmic Solution Once Daily Reduces Pupil Diameter and Improves Night Vision Disturbances
NYXOL
Presented at the American Association of Ophthalmology Meeting (Chicago)
Inhibition of APE1/Ref-1 redox activity with APX3330 blocks retinal angiogenesis in vitro and in vivo
APX3330
Vision Research 2011
Phentolamine Mesylate Treatment of Severe Night Vision Complaints
NYXOL
Presented at the American Association of Ophthalmology Meeting (Chicago)
